nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—peripheral nervous system neoplasm—malignant glioma	0.843	1	CtDrD
Topotecan—CYP3A4—Temozolomide—malignant glioma	0.0359	1	CbGbCtD
Topotecan—Metastatic neoplasm—Temozolomide—malignant glioma	0.00542	0.0671	CcSEcCtD
Topotecan—Acute leukaemia—Carmustine—malignant glioma	0.00377	0.0466	CcSEcCtD
Topotecan—Acute leukaemia—Temozolomide—malignant glioma	0.00364	0.045	CcSEcCtD
Topotecan—Paresis—Temozolomide—malignant glioma	0.00285	0.0353	CcSEcCtD
Topotecan—Irinotecan—CYP2B6—malignant glioma	0.0023	0.551	CrCbGaD
Topotecan—Myelosuppression—Carmustine—malignant glioma	0.00229	0.0284	CcSEcCtD
Topotecan—Myelosuppression—Temozolomide—malignant glioma	0.00222	0.0274	CcSEcCtD
Topotecan—Irinotecan—BCHE—malignant glioma	0.00188	0.449	CrCbGaD
Topotecan—Febrile neutropenia—Carmustine—malignant glioma	0.00179	0.0221	CcSEcCtD
Topotecan—Febrile neutropenia—Temozolomide—malignant glioma	0.00173	0.0214	CcSEcCtD
Topotecan—Interstitial lung disease—Carmustine—malignant glioma	0.00152	0.0188	CcSEcCtD
Topotecan—Lung disorder—Temozolomide—malignant glioma	0.00147	0.0182	CcSEcCtD
Topotecan—Interstitial lung disease—Temozolomide—malignant glioma	0.00147	0.0182	CcSEcCtD
Topotecan—Rigors—Temozolomide—malignant glioma	0.00127	0.0158	CcSEcCtD
Topotecan—TOP1—retina—malignant glioma	0.00127	0.0944	CbGeAlD
Topotecan—TOP1MT—central nervous system—malignant glioma	0.00126	0.0935	CbGeAlD
Topotecan—Extravasation—Carmustine—malignant glioma	0.00123	0.0153	CcSEcCtD
Topotecan—TOP1MT—cerebellum—malignant glioma	0.00123	0.0914	CbGeAlD
Topotecan—TOP1—telencephalon—malignant glioma	0.00117	0.0868	CbGeAlD
Topotecan—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00114	0.0142	CcSEcCtD
Topotecan—Pulmonary embolism—Carmustine—malignant glioma	0.00108	0.0133	CcSEcCtD
Topotecan—Respiratory failure—Temozolomide—malignant glioma	0.00106	0.0131	CcSEcCtD
Topotecan—Pulmonary embolism—Temozolomide—malignant glioma	0.00104	0.0129	CcSEcCtD
Topotecan—Neuropathy—Carmustine—malignant glioma	0.00101	0.0125	CcSEcCtD
Topotecan—TOP1MT—brain—malignant glioma	0.000999	0.0743	CbGeAlD
Topotecan—Neuropathy—Temozolomide—malignant glioma	0.000976	0.0121	CcSEcCtD
Topotecan—Neoplasm—Carmustine—malignant glioma	0.000973	0.012	CcSEcCtD
Topotecan—Neoplasm—Temozolomide—malignant glioma	0.00094	0.0116	CcSEcCtD
Topotecan—Sepsis—Carmustine—malignant glioma	0.000934	0.0116	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNFSF10—malignant glioma	0.000929	0.0415	CbGpPWpGaD
Topotecan—TOP1—medulla oblongata—malignant glioma	0.000918	0.0682	CbGeAlD
Topotecan—Ear pain—Temozolomide—malignant glioma	0.000885	0.011	CcSEcCtD
Topotecan—TOP1—midbrain—malignant glioma	0.000839	0.0623	CbGeAlD
Topotecan—TOP1—spinal cord—malignant glioma	0.000818	0.0608	CbGeAlD
Topotecan—TOP1—Circadian rythm related genes—NTRK3—malignant glioma	0.000788	0.0352	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—PTK2—malignant glioma	0.000704	0.0315	CbGpPWpGaD
Topotecan—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00068	0.00841	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000666	0.00824	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000656	0.0293	CbGpPWpGaD
Topotecan—TOP1—cerebellum—malignant glioma	0.000649	0.0482	CbGeAlD
Topotecan—Pancytopenia—Carmustine—malignant glioma	0.000641	0.00794	CcSEcCtD
Topotecan—Neutropenia—Carmustine—malignant glioma	0.000631	0.00781	CcSEcCtD
Topotecan—Pancytopenia—Temozolomide—malignant glioma	0.00062	0.00767	CcSEcCtD
Topotecan—Neutropenia—Temozolomide—malignant glioma	0.00061	0.00755	CcSEcCtD
Topotecan—Pneumonia—Carmustine—malignant glioma	0.000605	0.00749	CcSEcCtD
Topotecan—Weight increased—Temozolomide—malignant glioma	0.000594	0.00735	CcSEcCtD
Topotecan—Neuropathy peripheral—Carmustine—malignant glioma	0.00059	0.0073	CcSEcCtD
Topotecan—Stomatitis—Carmustine—malignant glioma	0.000587	0.00726	CcSEcCtD
Topotecan—Pneumonia—Temozolomide—malignant glioma	0.000585	0.00724	CcSEcCtD
Topotecan—Infestation—Temozolomide—malignant glioma	0.000582	0.0072	CcSEcCtD
Topotecan—Infestation NOS—Temozolomide—malignant glioma	0.000582	0.0072	CcSEcCtD
Topotecan—Neuropathy peripheral—Temozolomide—malignant glioma	0.00057	0.00706	CcSEcCtD
Topotecan—Stomatitis—Temozolomide—malignant glioma	0.000567	0.00702	CcSEcCtD
Topotecan—ABCG2—Iron uptake and transport—FTH1—malignant glioma	0.000554	0.0248	CbGpPWpGaD
Topotecan—Hepatobiliary disease—Temozolomide—malignant glioma	0.00055	0.00681	CcSEcCtD
Topotecan—ABCG2—Irinotecan Pathway—BCHE—malignant glioma	0.00055	0.0246	CbGpPWpGaD
Topotecan—Haemoglobin—Carmustine—malignant glioma	0.000543	0.00672	CcSEcCtD
Topotecan—Haemorrhage—Carmustine—malignant glioma	0.00054	0.00669	CcSEcCtD
Topotecan—Hypoaesthesia—Carmustine—malignant glioma	0.000538	0.00665	CcSEcCtD
Topotecan—TOP1—brain—malignant glioma	0.000527	0.0392	CbGeAlD
Topotecan—Haemoglobin—Temozolomide—malignant glioma	0.000525	0.0065	CcSEcCtD
Topotecan—Haemorrhage—Temozolomide—malignant glioma	0.000522	0.00646	CcSEcCtD
Topotecan—Hypoaesthesia—Temozolomide—malignant glioma	0.00052	0.00643	CcSEcCtD
Topotecan—Pharyngitis—Temozolomide—malignant glioma	0.000518	0.00641	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000497	0.0222	CbGpPWpGaD
Topotecan—Alopecia—Carmustine—malignant glioma	0.000477	0.00591	CcSEcCtD
Topotecan—Angiopathy—Temozolomide—malignant glioma	0.000474	0.00586	CcSEcCtD
Topotecan—Immune system disorder—Temozolomide—malignant glioma	0.000472	0.00584	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000471	0.0211	CbGpPWpGaD
Topotecan—Mediastinal disorder—Temozolomide—malignant glioma	0.000471	0.00583	CcSEcCtD
Topotecan—Malnutrition—Carmustine—malignant glioma	0.00047	0.00582	CcSEcCtD
Topotecan—Chills—Temozolomide—malignant glioma	0.000469	0.0058	CcSEcCtD
Topotecan—Alopecia—Temozolomide—malignant glioma	0.000461	0.00571	CcSEcCtD
Topotecan—Back pain—Carmustine—malignant glioma	0.000455	0.00563	CcSEcCtD
Topotecan—Malnutrition—Temozolomide—malignant glioma	0.000455	0.00563	CcSEcCtD
Topotecan—Back pain—Temozolomide—malignant glioma	0.00044	0.00544	CcSEcCtD
Topotecan—Anaemia—Carmustine—malignant glioma	0.000435	0.00538	CcSEcCtD
Topotecan—Ill-defined disorder—Temozolomide—malignant glioma	0.000422	0.00522	CcSEcCtD
Topotecan—ABCB1—blood vessel—malignant glioma	0.000421	0.0313	CbGeAlD
Topotecan—Leukopenia—Carmustine—malignant glioma	0.000421	0.00521	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00042	0.0188	CbGpPWpGaD
Topotecan—Anaemia—Temozolomide—malignant glioma	0.00042	0.0052	CcSEcCtD
Topotecan—Angioedema—Temozolomide—malignant glioma	0.000415	0.00514	CcSEcCtD
Topotecan—ABCG2—telencephalon—malignant glioma	0.000414	0.0308	CbGeAlD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.000413	0.0185	CbGpPWpGaD
Topotecan—Malaise—Temozolomide—malignant glioma	0.00041	0.00507	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2—malignant glioma	0.000408	0.0182	CbGpPWpGaD
Topotecan—Leukopenia—Temozolomide—malignant glioma	0.000407	0.00504	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—PML—malignant glioma	0.000403	0.018	CbGpPWpGaD
Topotecan—Chest pain—Carmustine—malignant glioma	0.0004	0.00496	CcSEcCtD
Topotecan—Myalgia—Carmustine—malignant glioma	0.0004	0.00496	CcSEcCtD
Topotecan—Cough—Temozolomide—malignant glioma	0.000397	0.00491	CcSEcCtD
Topotecan—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000393	0.0175	CbGpPWpGaD
Topotecan—Arthralgia—Temozolomide—malignant glioma	0.000387	0.00479	CcSEcCtD
Topotecan—Myalgia—Temozolomide—malignant glioma	0.000387	0.00479	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000384	0.0172	CbGpPWpGaD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000384	0.00476	CcSEcCtD
Topotecan—Discomfort—Temozolomide—malignant glioma	0.000382	0.00473	CcSEcCtD
Topotecan—Infection—Carmustine—malignant glioma	0.000381	0.00472	CcSEcCtD
Topotecan—Thrombocytopenia—Carmustine—malignant glioma	0.000376	0.00465	CcSEcCtD
Topotecan—Anaphylactic shock—Temozolomide—malignant glioma	0.000371	0.00459	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—TOP2A—malignant glioma	0.000369	0.0165	CbGpPWpGaD
Topotecan—Infection—Temozolomide—malignant glioma	0.000369	0.00456	CcSEcCtD
Topotecan—Anorexia—Carmustine—malignant glioma	0.000366	0.00453	CcSEcCtD
Topotecan—Nervous system disorder—Temozolomide—malignant glioma	0.000364	0.0045	CcSEcCtD
Topotecan—Thrombocytopenia—Temozolomide—malignant glioma	0.000363	0.0045	CcSEcCtD
Topotecan—Skin disorder—Temozolomide—malignant glioma	0.00036	0.00446	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—CASP3—malignant glioma	0.00036	0.0161	CbGpPWpGaD
Topotecan—Hyperhidrosis—Temozolomide—malignant glioma	0.000359	0.00444	CcSEcCtD
Topotecan—Anorexia—Temozolomide—malignant glioma	0.000354	0.00438	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00035	0.00433	CcSEcCtD
Topotecan—Paraesthesia—Carmustine—malignant glioma	0.000345	0.00427	CcSEcCtD
Topotecan—Dyspnoea—Carmustine—malignant glioma	0.000342	0.00424	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000338	0.00418	CcSEcCtD
Topotecan—Decreased appetite—Carmustine—malignant glioma	0.000334	0.00413	CcSEcCtD
Topotecan—Paraesthesia—Temozolomide—malignant glioma	0.000333	0.00412	CcSEcCtD
Topotecan—Gastrointestinal disorder—Carmustine—malignant glioma	0.000331	0.0041	CcSEcCtD
Topotecan—Dyspnoea—Temozolomide—malignant glioma	0.000331	0.00409	CcSEcCtD
Topotecan—Constipation—Carmustine—malignant glioma	0.000328	0.00406	CcSEcCtD
Topotecan—Pain—Carmustine—malignant glioma	0.000328	0.00406	CcSEcCtD
Topotecan—Dyspepsia—Temozolomide—malignant glioma	0.000327	0.00404	CcSEcCtD
Topotecan—ABCG2—medulla oblongata—malignant glioma	0.000325	0.0242	CbGeAlD
Topotecan—Decreased appetite—Temozolomide—malignant glioma	0.000322	0.00399	CcSEcCtD
Topotecan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00032	0.00396	CcSEcCtD
Topotecan—Fatigue—Temozolomide—malignant glioma	0.00032	0.00396	CcSEcCtD
Topotecan—Pain—Temozolomide—malignant glioma	0.000317	0.00393	CcSEcCtD
Topotecan—Constipation—Temozolomide—malignant glioma	0.000317	0.00393	CcSEcCtD
Topotecan—Feeling abnormal—Carmustine—malignant glioma	0.000316	0.00392	CcSEcCtD
Topotecan—Gastrointestinal pain—Carmustine—malignant glioma	0.000314	0.00389	CcSEcCtD
Topotecan—Feeling abnormal—Temozolomide—malignant glioma	0.000306	0.00378	CcSEcCtD
Topotecan—Abdominal pain—Carmustine—malignant glioma	0.000303	0.00376	CcSEcCtD
Topotecan—Body temperature increased—Carmustine—malignant glioma	0.000303	0.00376	CcSEcCtD
Topotecan—Gastrointestinal pain—Temozolomide—malignant glioma	0.000303	0.00375	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000299	0.0134	CbGpPWpGaD
Topotecan—ABCG2—Irinotecan Pathway—APC—malignant glioma	0.000299	0.0133	CbGpPWpGaD
Topotecan—ABCG2—midbrain—malignant glioma	0.000297	0.0221	CbGeAlD
Topotecan—Urticaria—Temozolomide—malignant glioma	0.000295	0.00365	CcSEcCtD
Topotecan—Body temperature increased—Temozolomide—malignant glioma	0.000293	0.00363	CcSEcCtD
Topotecan—Abdominal pain—Temozolomide—malignant glioma	0.000293	0.00363	CcSEcCtD
Topotecan—ABCG2—spinal cord—malignant glioma	0.00029	0.0216	CbGeAlD
Topotecan—TOP1—Circadian rythm related genes—NTRK1—malignant glioma	0.000287	0.0128	CbGpPWpGaD
Topotecan—Hypersensitivity—Carmustine—malignant glioma	0.000283	0.0035	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000278	0.0124	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.000277	0.0124	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—FLT1—malignant glioma	0.000276	0.0124	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000275	0.0123	CbGpPWpGaD
Topotecan—Asthenia—Carmustine—malignant glioma	0.000275	0.00341	CcSEcCtD
Topotecan—Hypersensitivity—Temozolomide—malignant glioma	0.000273	0.00338	CcSEcCtD
Topotecan—Asthenia—Temozolomide—malignant glioma	0.000266	0.00329	CcSEcCtD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000265	0.0119	CbGpPWpGaD
Topotecan—Diarrhoea—Carmustine—malignant glioma	0.000263	0.00325	CcSEcCtD
Topotecan—Pruritus—Temozolomide—malignant glioma	0.000262	0.00325	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNF—malignant glioma	0.000262	0.0117	CbGpPWpGaD
Topotecan—Dizziness—Carmustine—malignant glioma	0.000254	0.00314	CcSEcCtD
Topotecan—Diarrhoea—Temozolomide—malignant glioma	0.000254	0.00314	CcSEcCtD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000251	0.0112	CbGpPWpGaD
Topotecan—ABCB1—embryo—malignant glioma	0.000251	0.0187	CbGeAlD
Topotecan—TOP1—Circadian rythm related genes—NCOR1—malignant glioma	0.000251	0.0112	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00025	0.0112	CbGpPWpGaD
Topotecan—Dizziness—Temozolomide—malignant glioma	0.000245	0.00304	CcSEcCtD
Topotecan—Vomiting—Carmustine—malignant glioma	0.000244	0.00302	CcSEcCtD
Topotecan—Rash—Carmustine—malignant glioma	0.000242	0.003	CcSEcCtD
Topotecan—Dermatitis—Carmustine—malignant glioma	0.000242	0.00299	CcSEcCtD
Topotecan—ABCG2—Iron uptake and transport—TFRC—malignant glioma	0.000241	0.0108	CbGpPWpGaD
Topotecan—Headache—Carmustine—malignant glioma	0.00024	0.00298	CcSEcCtD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000239	0.0107	CbGpPWpGaD
Topotecan—Vomiting—Temozolomide—malignant glioma	0.000236	0.00292	CcSEcCtD
Topotecan—Rash—Temozolomide—malignant glioma	0.000234	0.0029	CcSEcCtD
Topotecan—Dermatitis—Temozolomide—malignant glioma	0.000234	0.00289	CcSEcCtD
Topotecan—Headache—Temozolomide—malignant glioma	0.000232	0.00288	CcSEcCtD
Topotecan—ABCG2—cerebellum—malignant glioma	0.00023	0.0171	CbGeAlD
Topotecan—Nausea—Carmustine—malignant glioma	0.000228	0.00282	CcSEcCtD
Topotecan—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000225	0.0101	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000224	0.00999	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.000223	0.00999	CbGpPWpGaD
Topotecan—ABCB1—retina—malignant glioma	0.000222	0.0165	CbGeAlD
Topotecan—Nausea—Temozolomide—malignant glioma	0.00022	0.00273	CcSEcCtD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000206	0.00922	CbGpPWpGaD
Topotecan—ABCB1—telencephalon—malignant glioma	0.000204	0.0152	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.0002	0.00895	CbGpPWpGaD
Topotecan—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000195	0.00874	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—malignant glioma	0.000195	0.00871	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000194	0.00867	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000192	0.00857	CbGpPWpGaD
Topotecan—ABCG2—brain—malignant glioma	0.000187	0.0139	CbGeAlD
Topotecan—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000183	0.00819	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PPARG—malignant glioma	0.00018	0.00803	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000171	0.00765	CbGpPWpGaD
Topotecan—CYP3A4—central nervous system—malignant glioma	0.000164	0.0122	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000163	0.0073	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000162	0.00726	CbGpPWpGaD
Topotecan—ABCB1—medulla oblongata—malignant glioma	0.000161	0.0119	CbGeAlD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—KDR—malignant glioma	0.000159	0.00712	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000155	0.00693	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000155	0.00692	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000153	0.00683	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000152	0.00681	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000151	0.00673	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.00015	0.00669	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000147	0.00659	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000147	0.00658	CbGpPWpGaD
Topotecan—ABCB1—midbrain—malignant glioma	0.000147	0.0109	CbGeAlD
Topotecan—ABCB1—spinal cord—malignant glioma	0.000143	0.0106	CbGeAlD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000141	0.00632	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000137	0.00611	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.00013	0.0058	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000128	0.00574	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PTEN—malignant glioma	0.000123	0.00551	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000119	0.0053	CbGpPWpGaD
Topotecan—ABCB1—central nervous system—malignant glioma	0.000116	0.00863	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000116	0.00519	CbGpPWpGaD
Topotecan—ABCB1—cerebellum—malignant glioma	0.000113	0.00844	CbGeAlD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000112	0.00498	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000107	0.00477	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000104	0.00467	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000103	0.00458	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.0001	0.00449	CbGpPWpGaD
Topotecan—CYP3A4—Irinotecan Pathway—APC—malignant glioma	9.95e-05	0.00445	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	9.94e-05	0.00444	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	9.86e-05	0.00441	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	9.8e-05	0.00438	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	9.36e-05	0.00418	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	9.25e-05	0.00414	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	9.24e-05	0.00413	CbGpPWpGaD
Topotecan—ABCB1—brain—malignant glioma	9.22e-05	0.00685	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	9.06e-05	0.00405	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—malignant glioma	8.78e-05	0.00393	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	8.77e-05	0.00392	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-C—malignant glioma	8.76e-05	0.00392	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TP53—malignant glioma	8.42e-05	0.00376	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	8.12e-05	0.00363	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	8.01e-05	0.00358	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	7.66e-05	0.00342	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	7.64e-05	0.00342	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	7.59e-05	0.00339	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL12B—malignant glioma	7.45e-05	0.00333	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.4e-05	0.00331	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—COX8A—malignant glioma	7.29e-05	0.00326	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—malignant glioma	6.79e-05	0.00304	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	6.75e-05	0.00302	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—FTH1—malignant glioma	6.67e-05	0.00298	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	6.58e-05	0.00294	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	6.03e-05	0.0027	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—RTEL1—malignant glioma	5.95e-05	0.00266	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	5.83e-05	0.00261	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOD—malignant glioma	5.67e-05	0.00254	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	5.54e-05	0.00248	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	5.48e-05	0.00245	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	5.3e-05	0.00237	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	5.22e-05	0.00233	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-B—malignant glioma	5.18e-05	0.00232	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	5.17e-05	0.00231	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	5.12e-05	0.00229	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	4.99e-05	0.00223	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	4.85e-05	0.00217	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-A—malignant glioma	4.8e-05	0.00215	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	4.72e-05	0.00211	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	4.32e-05	0.00193	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD80—malignant glioma	4.05e-05	0.00181	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	4.03e-05	0.0018	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	3.98e-05	0.00178	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	3.95e-05	0.00177	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	3.94e-05	0.00176	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	3.61e-05	0.00161	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	3.5e-05	0.00156	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	3.45e-05	0.00154	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—COX8A—malignant glioma	3.42e-05	0.00153	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—malignant glioma	3.3e-05	0.00147	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	3.26e-05	0.00146	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—RTEL1—malignant glioma	3.22e-05	0.00144	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IFNG—malignant glioma	3.2e-05	0.00143	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	3.15e-05	0.00141	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	3.07e-05	0.00137	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	3.07e-05	0.00137	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	3.02e-05	0.00135	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—malignant glioma	2.98e-05	0.00133	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ASMT—malignant glioma	2.9e-05	0.0013	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	2.9e-05	0.0013	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	2.86e-05	0.00128	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—malignant glioma	2.86e-05	0.00128	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—malignant glioma	2.85e-05	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL2—malignant glioma	2.85e-05	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	2.83e-05	0.00127	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTT1—malignant glioma	2.83e-05	0.00126	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	2.79e-05	0.00125	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BCAN—malignant glioma	2.73e-05	0.00122	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.67e-05	0.00119	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—PTGS1—malignant glioma	2.65e-05	0.00118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	2.57e-05	0.00115	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.54e-05	0.00113	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—malignant glioma	2.42e-05	0.00108	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	2.3e-05	0.00103	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—IDH2—malignant glioma	2.2e-05	0.000984	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—malignant glioma	2.07e-05	0.000927	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2B6—malignant glioma	2.07e-05	0.000925	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	2.06e-05	0.000921	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	2e-05	0.000892	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RTEL1—malignant glioma	1.98e-05	0.000886	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	1.97e-05	0.000882	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTP1—malignant glioma	1.96e-05	0.000876	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	1.93e-05	0.000864	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—IDH1—malignant glioma	1.89e-05	0.000846	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—COX8A—malignant glioma	1.85e-05	0.000826	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SPHK1—malignant glioma	1.83e-05	0.000819	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2C18—malignant glioma	1.79e-05	0.000802	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	1.78e-05	0.000796	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	1.68e-05	0.000751	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	1.59e-05	0.000713	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	1.57e-05	0.000703	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ASMT—malignant glioma	1.57e-05	0.000702	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	1.57e-05	0.000702	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	1.57e-05	0.0007	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.55e-05	0.000693	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.52e-05	0.000677	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BCAN—malignant glioma	1.48e-05	0.00066	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—malignant glioma	1.45e-05	0.000649	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.44e-05	0.000644	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.41e-05	0.000629	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.37e-05	0.000613	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS1—malignant glioma	1.36e-05	0.000608	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.32e-05	0.000591	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BCHE—malignant glioma	1.26e-05	0.000565	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC5A5—malignant glioma	1.25e-05	0.000558	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.19e-05	0.000533	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH2—malignant glioma	1.19e-05	0.000532	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.15e-05	0.000514	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COX8A—malignant glioma	1.14e-05	0.000509	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2B6—malignant glioma	1.12e-05	0.0005	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.1e-05	0.000491	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.07e-05	0.00048	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—IDH1—malignant glioma	1.02e-05	0.000457	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.02e-05	0.000457	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.01e-05	0.000454	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—malignant glioma	1.01e-05	0.00045	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SPHK1—malignant glioma	9.9e-06	0.000443	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAT—malignant glioma	9.79e-06	0.000438	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2C18—malignant glioma	9.7e-06	0.000434	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ASMT—malignant glioma	9.68e-06	0.000432	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	9.32e-06	0.000417	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOR1—malignant glioma	9.24e-06	0.000413	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BCAN—malignant glioma	9.1e-06	0.000407	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	9.02e-06	0.000403	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—malignant glioma	7.85e-06	0.000351	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.61e-06	0.00034	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—malignant glioma	7.54e-06	0.000337	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS1—malignant glioma	7.35e-06	0.000329	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH2—malignant glioma	7.33e-06	0.000328	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.89e-06	0.000308	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—malignant glioma	6.86e-06	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BCHE—malignant glioma	6.84e-06	0.000306	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A5—malignant glioma	6.75e-06	0.000302	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—malignant glioma	6.62e-06	0.000296	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—IDH1—malignant glioma	6.31e-06	0.000282	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.22e-06	0.000278	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SPHK1—malignant glioma	6.1e-06	0.000273	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—malignant glioma	6.03e-06	0.00027	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.98e-06	0.000267	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—malignant glioma	5.44e-06	0.000243	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAT—malignant glioma	5.29e-06	0.000237	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—malignant glioma	5.26e-06	0.000235	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—malignant glioma	5.21e-06	0.000233	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOR1—malignant glioma	5e-06	0.000223	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—malignant glioma	4.83e-06	0.000216	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—malignant glioma	4.54e-06	0.000203	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS1—malignant glioma	4.53e-06	0.000202	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BCHE—malignant glioma	4.21e-06	0.000188	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.16e-06	0.000186	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—malignant glioma	4.07e-06	0.000182	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—malignant glioma	3.71e-06	0.000166	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—malignant glioma	3.58e-06	0.00016	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—malignant glioma	3.35e-06	0.00015	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—malignant glioma	3.26e-06	0.000146	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAT—malignant glioma	3.26e-06	0.000146	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—malignant glioma	3.21e-06	0.000143	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOR1—malignant glioma	3.08e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—malignant glioma	2.84e-06	0.000127	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—malignant glioma	2.82e-06	0.000126	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—malignant glioma	2.62e-06	0.000117	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—malignant glioma	2.51e-06	0.000112	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—malignant glioma	2.46e-06	0.00011	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.29e-06	0.000102	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—malignant glioma	2.21e-06	9.86e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.01e-06	8.99e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.75e-06	7.83e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—malignant glioma	1.74e-06	7.76e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—malignant glioma	1.73e-06	7.75e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—malignant glioma	1.51e-06	6.77e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—malignant glioma	1.42e-06	6.33e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.07e-06	4.77e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—malignant glioma	8.72e-07	3.9e-05	CbGpPWpGaD
